Viatris (VTRS): Reassessing Valuation After Recent Share Price Gains and Evolving Investor Sentiment [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
See our latest analysis for Viatris. Zooming out, that recent 1 month share price return of around 14% and a roughly 21% gain over 3 months stands in contrast to a still negative year to date share price return. This suggests sentiment has only recently started to turn as investors reassess Viatris potential earnings power and risk profile at an $11.93 share price and a modest 1 year total shareholder return close to flat. If Viatris has you rethinking healthcare exposure, this is a good moment to explore other potential opportunities across healthcare stocks and see what else fits your strategy. With the stock still trading at a sizable intrinsic discount, yet only a touch below consensus targets, investors now face a key question: Is Viatris genuinely undervalued, or is the market already pricing in the next leg of growth? With Viatris last closing at $11.93 against a narrative fair value of about $12.44, the story leans toward modest upside driven by improving fundamentals
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris: Looks Cheap, But Faces Continued Contraction [Seeking Alpha]Seeking Alpha
- Is Viatris' Shift Into Complex Therapies Altering The Investment Case For VTRS? [Yahoo! Finance]Yahoo! Finance
- Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates [Yahoo! Finance]Yahoo! Finance
- 1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm [Yahoo! Finance]Yahoo! Finance
- Viatris Provides Pipeline Update on Four Regulatory MilestonesPR Newswire
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 12/8/25 - Form 8-K
- 12/5/25 - Form 8-K
- 12/5/25 - Form 8-K/A
- VTRS's page on the SEC website